Company Overview
Development, commercialisation and sale of assistive communications technology systems within the disability sector.
Website | www.controlbionics.com |
---|---|
Head Office | Camberwell VIC |
Registry | Automic Registry Services |
CEO | Robert Wong |
Chair Person | Roger Hawke |
GICS Industry | Health Care Equipment & Services |
Sub Industry | Health Care Equipment |
Sector | Health Care |
Market Cap | $10 m |
---|---|
Shares on Issue | 50 m |
Status | Trading |
Last Price | |
Change | |
52 Week H/L | |
VWAP | |
Bid/Ask |
Directors and Management
Mr Damian Lismore
Non-Executive Director 30/09/2020
Mr Lismore has commercial, international and listed company experience (both ASX and NASDAQ), covering many industries including healthcare and technology. In his executive career, he held CEO, CFO and Company Secretarial roles and continues to act as an advisor to CEOs, boards and business owners. Damian is currently CFO of Scout Bio Inc, a Frazier Healthcare Partners backed company. He is Chair of the Risk committee.
GMAICD, BA (Hons Acc), MCA(ANZ), FCA(Ireland), Male
Mr Lindsay John Phillips
Non-Executive Director 07/08/2014
Mr Phillips is an experienced private equity fund Managing Director and Chairman. Lindsay first invested in Control Bionics in 2005. Lindsay was Managing Director of Lazard Australia Private Equity from 2007 to 2012. Since 2012 Lindsay has been Chairman of Phoenix Development Fund and Nightingale Partners. He is a member of the Risk committee.
BCom, MCA(ANZ) Male
Mr Roger David Hawke
Non-Executive Chairman,Non-Executive Director 19/09/2018
Mr Hawke has over 30 years of experience in the telecommunications and technology space, having retired after 8 years as CEO & Managing Director of Crown Castle Australia/Axicom, and brings experience particularly in Technology, Operations, Sales and Management. He is a member of the Risk Management committee.
BE, MES, MBA,MAICD Male
Mr Robert William Wong
Chief Executive Officer,Managing Director 29/09/2020
Mr Wong has over 25 years of experience with multinational businesses in senior management, marketing, and operational roles. He is also an entrepreneur and angel investor having been involved with several technology start-up businesses. He formerly held the position of CEO at AIMIA Digital Industry Association of Australia. Rob joined Control Bionics in early 2017 and he has led the way in developing the latest product, the NeuroNode Trilogy. Rob has spent much of his time with Control Bionics presenting to industry leaders, forming research and development relations, and working hands-on with clients across the world. He is a member of the Risk committee.
BBus,MBA, Male
Mr Peter Shann Ford
Executive Director 26/07/2005
Mr Ford is the Founder and Director of Innovation at Control Bionics Limited. After spending three years as a founding programmer at the US Veterans Administration Medical Center Rehabilitation R&D Laboratory in Atlanta - one of the first of its kind in the USA - while a news anchor at CNN and CNN2, Peter began consulting to therapists and disability clients in innovative Assistive Technology, including bionics and robotics. From 2002-2007 he Beta-tested evolving prototypes of his coding with Prof Hawking at Texas A&M University and Cambridge University, and with doctors and their patients and clients in the USA, Australia and New Zealand. In 2005, with an initial investment from Phoenix Development Fund in Australia, Control Bionics was born. He is a member of the Risk committee.
Male
Top 20 Shareholders
Name | Shares | % | |
---|---|---|---|
1. | Peter Shann Ford | 21,258,313 | 25.45 |
2. | Nightingale Partners Pty Limited | 9,117,123 | 10.91 |
3. | Phoenix Development Fund Limited | 8,019,581 | 9.60 |
4. | Bnp Paribas Noms Pty Ltd <Drp> | 4,488,696 | 5.37 |
5. | Loidl Nominees Pty Ltd <Loidl Family A/C> | 2,541,289 | 3.04 |
6. | R & R Wong Holdings Pty Limited <R & R Wong Family Super A/C> | 2,540,616 | 3.04 |
7. | Pacific Atlantic Commerce Pty Ltd <Corcillum Super Fund A/C> | 1,396,182 | 1.67 |
8. | Dowe Holdings Pty Limited | 1,121,893 | 1.34 |
9. | Windward Capital Pty Ltd <S&L Rix Superfund A/C> | 1,118,863 | 1.34 |
10. | Brindle Holdings Pty Ltd <O Connor S/F A/C> | 1,100,000 | 1.32 |
11. | Santios Pty Limited <The Mcmurray Family A/C> | 999,219 | 1.20 |
12. | National Nominees Limited | 845,311 | 1.01 |
13. | James Schorey | 834,168 | 1.00 |
14. | Nandaroo Pty Limited | 792,202 | 0.95 |
15. | Robert Allwell Pty Ltd <Robert Allwell Superfund A/C> | 781,757 | 0.94 |
16. | Paula Darling | 781,757 | 0.94 |
17. | Hafnium Management Pty Ltd <Hafnium Family A/C> | 758,478 | 0.91 |
18. | Paul Mahon | 701,183 | 0.84 |
19. | Darrell G Blandford | 611,303 | 0.73 |
20. | Dianna Louise Cooke | 575,307 | 0.69 |
Director Transactions
Date | Name | Qty | Value | Direction | Notes |
---|---|---|---|---|---|
27/09/2021 | Lindsay Phillips | 18,000 | $11,861 | Buy | On-market trade. |
22/09/2021 | Lindsay Phillips | 51,037 | $33,378 | Buy | On-market trade. |
20/09/2021 | Lindsay Phillips | 71,991 | $46,619 | Buy | On-market trade. |
18/03/2021 | Damian Lismore | 25,000 | $15,250 | Buy | On-market trade. |